Alexander Winkelmann

5.0k total citations
43 papers, 828 citations indexed

About

Alexander Winkelmann is a scholar working on Pathology and Forensic Medicine, Neurology and Immunology. According to data from OpenAlex, Alexander Winkelmann has authored 43 papers receiving a total of 828 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Pathology and Forensic Medicine, 13 papers in Neurology and 12 papers in Immunology. Recurrent topics in Alexander Winkelmann's work include Multiple Sclerosis Research Studies (31 papers), Peripheral Neuropathies and Disorders (12 papers) and SARS-CoV-2 and COVID-19 Research (7 papers). Alexander Winkelmann is often cited by papers focused on Multiple Sclerosis Research Studies (31 papers), Peripheral Neuropathies and Disorders (12 papers) and SARS-CoV-2 and COVID-19 Research (7 papers). Alexander Winkelmann collaborates with scholars based in Germany, Austria and Spain. Alexander Winkelmann's co-authors include Uwe K. Zettl, Micha Loebermann, Emil C. Reisinger, Hans‐Peter Hartung, Michael Hecker, Paulus Rommer, Hartmut Hengel, Reiner Benecke, Robert Patejdl and Brunhilde Schweiger and has published in prestigious journals such as Brain, Scientific Reports and Frontiers in Immunology.

In The Last Decade

Alexander Winkelmann

41 papers receiving 808 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alexander Winkelmann Germany 15 585 239 193 164 156 43 828
Cinzia Cordioli Italy 16 591 1.0× 338 1.4× 315 1.6× 145 0.9× 206 1.3× 29 837
Peter Wipfler Austria 17 362 0.6× 178 0.7× 142 0.7× 168 1.0× 166 1.1× 56 658
Sarah Laurent Germany 13 360 0.6× 371 1.6× 120 0.6× 213 1.3× 133 0.9× 19 828
David Magalashvili Israel 16 810 1.4× 385 1.6× 441 2.3× 222 1.4× 150 1.0× 48 1.1k
Paolo Ripellino Switzerland 14 282 0.5× 154 0.6× 88 0.5× 272 1.7× 147 0.9× 44 786
Neil Minton United States 11 462 0.8× 146 0.6× 61 0.3× 155 0.9× 133 0.9× 24 818
Antonios Bayas Germany 19 459 0.8× 224 0.9× 77 0.4× 301 1.8× 210 1.3× 52 1.2k
Anna Christine Nilsson Denmark 18 203 0.3× 308 1.3× 219 1.1× 134 0.8× 51 0.3× 66 792
Juha-Pekka Erälinna Finland 14 406 0.7× 161 0.7× 59 0.3× 196 1.2× 154 1.0× 24 748
Olivier Heinzlef France 10 383 0.7× 205 0.9× 201 1.0× 41 0.3× 110 0.7× 25 604

Countries citing papers authored by Alexander Winkelmann

Since Specialization
Citations

This map shows the geographic impact of Alexander Winkelmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander Winkelmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander Winkelmann more than expected).

Fields of papers citing papers by Alexander Winkelmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander Winkelmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander Winkelmann. The network helps show where Alexander Winkelmann may publish in the future.

Co-authorship network of co-authors of Alexander Winkelmann

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander Winkelmann. A scholar is included among the top collaborators of Alexander Winkelmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander Winkelmann. Alexander Winkelmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hecker, Michael, Brit Fitzner, Dirk Koczan, et al.. (2024). Differential gene expression in B cells and T helper cells following high-dose glucocorticoid therapy for multiple sclerosis relapse. Biomedicine & Pharmacotherapy. 175. 116721–116721. 1 indexed citations
2.
Winkelmann, Alexander, et al.. (2023). Side effects following vaccination in multiple sclerosis: a prospective, multi-centre cohort study. Scientific Reports. 13(1). 14480–14480. 1 indexed citations
3.
Hecker, Michael, Brit Fitzner, Alexander Winkelmann, et al.. (2022). Implication of genetic variants in primary microRNA processing sites in the risk of multiple sclerosis. EBioMedicine. 80. 104052–104052. 6 indexed citations
4.
Winkelmann, Alexander, Micha Loebermann, Michael Barnett, Hans‐Peter Hartung, & Uwe K. Zettl. (2022). Vaccination and immunotherapies in neuroimmunological diseases. Nature Reviews Neurology. 18(5). 289–306. 37 indexed citations
5.
Zrzavy, Tobias, Micha Löbermann, Alexander Winkelmann, et al.. (2021). Die Corona-Pandemie und Multiple Sklerose: Impfungen und deren Implikationen für Patienten – Teil 1: Empfehlungen. Der Nervenarzt. 92(12). 1276–1282. 2 indexed citations
6.
Winkelmann, Alexander, Micha Löbermann, & Uwe K. Zettl. (2019). Varicella-zoster- und Herpes-zoster-Impfindikation bei Multipler Sklerose: aktuelle Situation. Der Nervenarzt. 90(12). 1254–1260. 2 indexed citations
7.
Zrzavy, Tobias, Herwig Kollaritsch, Paulus Rommer, et al.. (2019). Vaccination in Multiple Sclerosis: Friend or Foe?. Frontiers in Immunology. 10. 1883–1883. 56 indexed citations
8.
Hecker, Michael, Dirk Koczan, Brit Fitzner, et al.. (2018). Transcriptome profiling of peripheral blood immune cell populations in multiple sclerosis patients before and during treatment with a sphingosine‐1‐phosphate receptor modulator. CNS Neuroscience & Therapeutics. 24(3). 193–201. 19 indexed citations
9.
Winkelmann, Alexander, Paulus Rommer, Michael Hecker, & Uwe K. Zettl. (2018). Intravenous immunoglobulin treatment in multiple sclerosis: A prospective, rater‐blinded analysis of relapse rates during pregnancy and the postnatal period. CNS Neuroscience & Therapeutics. 25(1). 78–85. 11 indexed citations
10.
Hecker, Michael, Dirk Koczan, Brit Fitzner, et al.. (2016). High-Resolution Expression Profiling of Peripheral Blood CD8+ Cells in Patients with Multiple Sclerosis Displays Fingolimod-Induced Immune Cell Redistribution. Molecular Neurobiology. 54(7). 5511–5525. 15 indexed citations
11.
Rommer, Paulus, Mazen Abu‐Mugheisib, Wolfgang Köehler, et al.. (2014). Effects of intrathecal triamincinolone-acetonide treatment in MS patients with therapy-resistant spasticity. Spinal Cord. 53(2). 109–113. 10 indexed citations
12.
Salmen, Anke, M. Starck, Alexander Winkelmann, et al.. (2014). Lack of efficacy of mitoxantrone in primary progressive Multiple Sclerosis irrespective of pharmacogenetic factors: A multi-center, retrospective analysis. Journal of Neuroimmunology. 278. 277–279. 14 indexed citations
13.
Rommer, Paulus, Axel Petzold, Hayrettin Tumani, et al.. (2014). Effects of Repeated Intrathecal Triamcinolone-Acetonide Application on Cerebrospinal Fluid Biomarkers of Axonal Damage and Glial Activity in Multiple Sclerosis Patients. Molecular Diagnosis & Therapy. 18(6). 631–637. 13 indexed citations
14.
Galea, Ian, Christian Lederer, Ain Neuhaus, et al.. (2012). A Web‐based tool for personalized prediction of long‐term disease course in patients with multiple sclerosis. European Journal of Neurology. 20(7). 1107–1109. 18 indexed citations
15.
Loebermann, Micha, Alexander Winkelmann, Hans‐Peter Hartung, et al.. (2012). Vaccination against infection in patients with multiple sclerosis. Nature Reviews Neurology. 8(3). 143–151. 70 indexed citations
16.
Winkelmann, Alexander, Micha Löbermann, Emil C. Reisinger, & Uwe K. Zettl. (2011). Therapie der Multiplen Sklerose mit Fingolimod. Der Nervenarzt. 83(2). 236–242. 3 indexed citations
17.
Rommer, Paulus, Robert Patejdl, Alexander Winkelmann, Reiner Benecke, & Uwe K. Zettl. (2011). Rituximab for Secondary Progressive Multiple Sclerosis. CNS Drugs. 25(7). 607–613. 15 indexed citations
18.
Ahsen, Nicolas von, Niels Kruse, Brian E. Huber, et al.. (2009). ABC-transporter gene-polymorphisms are potential pharmacogenetic markers for mitoxantrone response in multiple sclerosis. Brain. 132(9). 2517–2530. 55 indexed citations
19.
Winkelmann, Alexander, et al.. (2008). Cerebral MRI lesions and anti-tumor necrosis factor-alpha therapy. Journal of Neurology. 255(S6). 109–114. 23 indexed citations
20.
Winkelmann, Alexander, et al.. (2007). Cognitive impairment in multiple sclerosis. Journal of Neurology. 254(S2). II35–II42. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cinzia Cordioli Breakdown of academic impact, for papers by Peter Wipfler Breakdown of academic impact, for papers by Sarah Laurent Breakdown of academic impact, for papers by David Magalashvili Breakdown of academic impact, for papers by Paolo Ripellino Breakdown of academic impact, for papers by Neil Minton Breakdown of academic impact, for papers by Antonios Bayas Breakdown of academic impact, for papers by Anna Christine Nilsson Breakdown of academic impact, for papers by Juha-Pekka Erälinna Breakdown of academic impact, for papers by Olivier Heinzlef
Rankless by CCL
2026